Mgta-117, an Anti-CD117-Amanitin Antibody-Drug Conjugate, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics, and Pharmacodynamics Initial Findings from a Phase 1/2 Study
Year: 2023
Type: article
Authors: Mark Juckett, Peter Westervelt, Partow Kebriaei, Andrew S. Artz, Onyee Chan, Dr. Philip L. McCarthy, Sherif S. Farag, Anurag K. Singh, Eytan Stein, Ji Hyun Lee, Alison Occhiuti, Jeanie Tang, David Santos, Kirk Bertelsen, Balaji Mahender, Nicole Henry, Donald Pardy, June Li, Christian Zdybowicz, Shawn Rose
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W4319263254